Biomedical Analyzer offers throughput to 990 tests/hour.
Press Release Summary:
Modular UniCel DxC 600 Synchron clinical analyzer features onboard capacity of 65 reagents and throughput up to 990 tests per hour. System provides results for 96 basic metabolic panels within one hour. More than 100 tests are available on system, including general chemistries, critical care chemistries, proteins, serologies and esoteric chemistries, as well as therapeutic drug monitoring and drugs-of-abuse tests.
Original Press Release:
Beckman Coulter Launches UniCel® DxC 600 Synchron® Chemistry System, Advances Workstation Consolidation Strategy
FULLERTON, Calif., Jan. 28 -- Representing the second in its series of UniCel brand laboratory instruments, Beckman Coulter, Inc. (NYSE:BEC) announced today the release of the UniCel DxC 600 Synchron clinical system. The next-generation system builds upon the technology of the company's market-leading SYNCHRON clinical analyzers to offer a broad test menu while providing highly accurate results and exceptional reliability. The UniCel DxC 600 features onboard capacity of 65 reagents and throughput up to 990 tests per hour. The system provides results for 96 basic metabolic panels within one hour. More than 100 tests are available on the system, including general chemistries, critical care chemistries, proteins, serologies and esoteric chemistries, as well as therapeutic drug monitoring and drugs-of-abuse tests. "Each modular system in the UniCel family is designed for easy multi-platform configuration, management and connectivity, enabling labs to consolidate workstations, optimize workload and labor resources, and reduce costs," said Jeff McHugh, vice president of lab systems and routine testing for Beckman Coulter's diagnostics division. "The UniCel line also improves productivity by enabling healthcare networks to standardize inventory and lab testing methods across multiple locations to increase consistency and quality of results reporting." The addition of the DxC 600 to Beckman Coulter's growing line of UniCel brand instruments reflects the company's strategy to deliver standardized, seamless product lines with flexible connectivity for greater workstation consolidation. The first in the series, the UniCel® DxI 800 Access® immunoassay system, debuted in 2003 and can perform up to 400 tests per hour. Beckman Coulter, Inc. is a leading manufacturer of biomedical testing instrument systems, tests and supplies that simplify and automate laboratory processes. Spanning the biomedical testing continuum -- from pioneering medical research and clinical trials to laboratory diagnostics and point-of-care testing -- Beckman Coulter's 200,000 installed systems provide essential biomedical information to enhance health care around the world. The company, based in Fullerton, Calif., reported 2004 annual sales of $2.4 billion with 64 percent of this amount generated by recurring revenue from supplies, test kits and services. For more information, visit www.beckmancoulter.com or call (800) 352-3433.
